Here is more information on Wegovy, how to decide if it’s right for you, and what you need to know about the Wegovy ...

Veru said Monday that its investigational drug helped preserve lean mass in patients taking the obesity treatment Wegovy, though some experts were skeptical that the topline results were adequate ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial ... That compared with 15.6% weight loss among people taking the currently approved 2.4-mg dose, and 3.9% ...

In a Phase 2b trial, older patients taking Novo Nordisk’s Wegovy and Veru’s experimental drug, called enobosarm, lost on average 1.2% of lean mass after 16 weeks, compared with a 4.1% loss in ...